Atlas Trials

Distal Urethral Cancer

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Distal Urethral Cancer

RecordFirmDate
Afatinib in Advanced Refractory Urothelial Cancer (NCT02122172)University of Chicago2017-09-13
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer (NCT01611662)Fox Chase Cancer Center2012-05-29
Pazopanib in Treating Patients With Metastatic Urothelial Cancer (NCT00471536)National Cancer Institute (NCI)2008-08-01
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function (NCT00478361)M.D. Anderson Cancer Center2007-04-01
VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00407485)National Cancer Institute (NCI)2006-11-01
Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium (NCT00112905)National Cancer Institute (NCI)2005-10-01
Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00004856)National Cancer Institute (NCI)2002-07-01
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074)National Cancer Institute (NCI)1999-08-01

Track Distal Urethral Cancer automatically

Every clearance here is in the API, with alerts when new ones post.